Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) CRISPR Plasmids

Santa Cruz Biotechnology, Inc. offers a broad range of gene editing products including CRISPR/Cas9 Knockout and CRISPR Double Nickase plasmids for gene silencing. Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) gene silencers are available as Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) CRISPR/Cas9 Knockout plasmids and Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) Double Nickase Plasmids. Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) CRISPR/dCas9 Activation Plasmids and CRISPR Lenti Activation Systems for gene activation are also available. Gene silencers and activators are useful for gene studies in combination with antibodies used for protein detection.